How long have GLP-1 drugs been on the market
Additionally, BPC-157 has been shown to improve gut health, which is essential for overall well-being
When a new prescription drug enters the market, the question for employers isnt just does it work? Its what does covering it mean for our people, our plan, and our longterm costs? That question became especially relevant in early 2026, when an oral version of Wegovy entered the market with widespread media coverage
Tirzepatide is not appropriate for individuals with a history of medullary thyroid carcinoma, MEN2 syndrome, severe gastroparesis, or certain endocrine conditions
Patients are encouraged to seek FDA-approved medications and consult licensed healthcare providers for weight management therapies